Abstract
Drug-Induced Orthostatic Hypotension (DOH) is considered as one of seconder Orthostatic Hypotension (OH) and it usually leads to OH symptoms such as light-headedness, syncope, falls, injury in the elderly. DOH originates from dysfunction of autonomic tone that regulates blood pressure and it can lead to OH or trigger easily OH by medications. As a clinically significant finding DOH or OH, is defined as a transient blood pressure decrease (≥40 mmHg systolic blood pressure and/or ≥20 mmHg diastolic blood pressure) within 15 s of standing. Symptoms of patients suffering from OH or DOH are light-headedness, dizziness, nausea, weakness or blurred vision during in standing position. OH, is very common, affecting one in five community-dwelling older people, the prevalence ranges from 5% to 30%, increases with age and mostly seen in patients ≥65 years old. Especially, older age is the most important risk factor for DOH, the same as for alpha-adrenergic receptor antagonists, calcium channel blockers, diuretics, angiotensin converting enzyme inhibitors, antipsychotics, β-adrenergic receptor blockers, tricyclic antidepressants, anti-Parkinsonian drugs, and polypharmacy. DOH hypotension is a frequent finding and issue in geriatric patients and removal of the triggering factors should be the first action.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ACE:
-
Angiotensin Converting Enzyme
- CCBs:
-
Calcium Channel blockers
- DOH:
-
Drug-Induced Orthostatic Hypotension
- L-DOPA:
-
Levodopa
- OH:
-
Orthostatic Hypotension
- PD:
-
Parkinson’s Disease
- TCAs:
-
Tricyclic Antidepressants
References
Ricci F, De Caterina R, Fedorowski A. Orthostatic hypotension: epidemiology, prognosis, and treatment. J Am Coll Cardiol. 2015;66:848–60.
Mills PB, Fung CK, Travlos A, Krassioukov A. Nonpharmacologic management of orthostatic hypotension: a systematic review. Arch Phys Med Rehabil. 2015;96(2):366–75.
Mets TF. Drug-induced orthostatic hypotension in older patients. Drugs Aging. 1995;6(3):219–28.
Saedon NI, Pin Tan M, Frith J. The prevalence of orthostatic hypotension: a systematic review and meta-analysis. J Gerontol A Biol Sci Med Sci. 2020;75(1):117–22.
Joseph A, Wanono R, Flamant M, Vidal-Petiot E. Orthostatic hypotension: a review. Nephrol Ther. 2017;13:S55–67.
Méndez AS, Melgarejo JD, Mena LJ, Chávez CA, González AC, Boggia J, Terwilliger JD, Lee JH, Maestre GE. Risk factors for orthostatic hypotension: differences between elderly men and women. Am J Hypertens. 2018;31(7):797–803.
Low PA. Prevalence of orthostatic hypotension. Clin Auton Res. 2008;18(1):8–13.
Frith J, Parry SW. New horizons in orthostatic hypotension. Age Ageing. 2017;46(2):168–74.
Gangavati A, Hajjar I, Quach L, et al. Hypertension, orthostatic hypotension, and the risk of falls in a community-dwelling elderly population: the maintenance of balance, independent living, intellect, and zest in the elderly of Boston study. J Am Geriatr Soc. 2011;59:383–9.
Gupta V, Lipsitz LA. Orthostatic hypotension in the elderly: diagnosis and treatment. Am J Med. 2007;120:841–7.
Metzler M, Duerr S, Granata R, Krismer F, Robertson D, Wenning GK. Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management. J Neurol. 2013;260(9):2212–9.
Gami AS, Hodge DO, Herges RM, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol. 2007;49:565–71.
Okin PM, Wachtell K, Kjeldsen SE, et al. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study. Circ Arrhythm Electrophysiol. 2008;1:337–43.
Nakagawa H, Scherlag BJ, Patterson E, et al. Pathophysiologic basis of autonomic ganglionated plexus ablation in patients with atrial fibrillation. Heart Rhythm. 2009;6:S26–34.
Fedorowski A, Burri P, Struck J, et al. Novel cardiovascular biomarkers in unexplained syncopal attacks: the SYSTEMA cohort. J Intern Med. 2013;273:359–67.
Berger R, Pacher R. The role of the endothelin system in myocardial infarction—new therapeutic targets? Eur Heart J. 2003;24:294–6.
Kanjwal K, George A, Figueredo VM, et al. Orthostatic hypotension: definition, diagnosis and management. J Cardiovasc Med (Hagerstown). 2015;16:75–81.
Goldstein DS, Sharabi Y. Neurogenic orthostatic hypotension: a pathophysiological approach. Circulation. 2009;119:139–46.
Grubb BP, Karas B. Clinical disorders of the autonomic nervous system associated with orthostatic intolerance: an overview of classification, clinical evaluation, and management. Pacing Clin Electrophysiol. 1999;22:798–810.
Trahair LG, Horowitz M, Jones KL. Postprandial hypotension: a systematic review. J Am Med Dir Assoc. 2014;15:394–409.
Moya A, Sutton R, Ammirati F, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30:2631–71.
Poon IO, Braun U. High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. J Clin Pharm Ther. 2005;30:173–8.
Rutan GH, Hermanson B, Bild DE, et al. Orthostatic hypotension in older adults. The cardiovascular health study. CHS collaborative research group. Hypertension. 1992;19:508–19.
Bradley JG, Davis KA. Orthostatic hypotension. Am Fam Physician. 2003;68:2393–8.
Perez-Lloret S, Rey MV, Fabre N, et al. Factors related to orthostatic hypotension in Parkinson’s disease. Parkinsonism Relat Disord. 2012;18:501–5.
Pathak A, Lapeyre-Mestre M, Montastruc JL, et al. Heat-related morbidity in patients with orthostatic hypotension and primary autonomic failure. Mov Disord. 2005;20:1213–9.
Narkiewicz K, Cooley RL, Somers VK. Alcohol potentiates orthostatic hypotension: implications for alcohol-related syncope. Circulation. 2000;101:398–402.
Schoenberger JA. Drug-induced orthostatic hypotension. Drug Saf. 1991;6(6):402–7.
Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci. 2011;161:46–8.
Goldstein DS, Robertson D, Esler M, et al. Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med. 2002;137:753–63.
Chopra S, Baby C, Jacob JJ. Neuro-endocrine regulation of blood pressure. Indian J Endocrinol Metab. 2011;15(Suppl 4):S281–8.
Dampney RA, Coleman MJ, Fontes MA, et al. Central mechanisms underlying short- and longterm regulation of the cardiovascular system. Clin Exp Pharmacol Physiol. 2002;29:261–8.
Douglas E. Rollins, Donald K. Blumenthal. Workbook and casebook for Goodman and Gilman's the pharmacological basis of therapeutics, chapter 15: drug therapy of hypertension, edema, and disorders of sodium and water balance, © 2016, by the McGraw-Hill Companies, Inc., Printed in the United States of America.
Wadei HM, Textor SC. The role of the kidney in regulating arterial blood pressure. Nat Rev Nephrol. 2012;8:602–9.
Rhaleb NE, Yang XP, Carretero OA. The kallikrein-kinin system as a regulator of cardiovascular and renal function. Compr Physiol. 2011;1:971–93.
Katzung BG, Trevor AJ, editors. Basic & clinical pharmacology. New York: McGraw-hill Education; 2017.
Perlmuter LC, Sarda G, Casavant V, Mosnaim AD. A review of the etiology, asssociated comorbidities, and treatment of orthostatic hypotension. Am J Ther. 2013;20(3):279–91.
Rüster C, Wolf G. Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol. 2006;17(11):2985–91.
Goswami N, Blaber AP, Hinghofer-Szalkay H, Montani JP. Orthostatic intolerance in older persons: etiology and countermeasures. Front Physiol. 2017;8:803.
Monahan KD, Dinenno FA, Seals DR, Clevenger CM, Desouza CA, Tanaka H. Age-associated changes in cardiovagal baroreflex sensitivity are related to central arterial compliance. Am J Phys Heart Circ Phys. 2001;281(1):H284–9.
Juraschek SP, Daya N, Appel LJ, Miller ER, Windham BG, Pompeii L, Griswold ME, Kucharska-Newton A, Selvin E. Orthostatic hypotension in middle-age and risk of falls. Am J Hypertens. 2017;30(2):188–95.
Liguori I, Russo G, Coscia V, Aran L, Bulli G, Curcio F, Della-Morte D, Gargiulo G, Testa G, Cacciatore F, Bonaduce D. Orthostatic hypotension in the elderly: a marker of clinical frailty? J Am Med Dir Assoc. 2018;19(9):779–85.
The list of drugs with orthastatic hypotension and hypotension drug. Web application; SIDER 4.1:Side Effect Resource; 2020, January 9. http://sideeffects.embl.de/se/C0020649/
Finucane C, O’Connell MD, Donoghue O, et al. I mpaired orthostatic blood pressure recovery is associated with unexplained and injurious falls. J Am Geriatr Soc. 2017;65:474–82.
Bylund DB (2009) Norepinephrine: Adrenergic Receptors. 1231–1236.
Testa G, Ceccofiglio A, Mussi C, Bellelli G, Nicosia F, Bo M, Riccio D, Curcio F, Martone AM, Noro G, Landi F. Hypotensive drugs and syncope due to orthostatic hypotension in older adults with dementia (syncope and dementia study). J Am Geriatr Soc. 2018;66(8):1532–7.
Laurent S. Antihypertensive drugs. Pharmacol Res. 2017;124:116–25.
Davidson E, Fuchs J, Rotenberg Z, Weinberger I, Agmon J. Drug-related syncope. Clin Cardiol. 1989;12(10):577–80.
Elliott WJ, Ram CV. Calcium channel blockers. J Clin Hypertens (Greenwich). 2011;13(9):687–9.
Frishman WH. Beta-adrenergic receptor blockers. Adverse effects and drug interactions. Hypertension. 1988;11(3):21–9.
White WB. Hypotension with postural syncope secondary to the combination of chlorpromazine and captopril. Arch Intern Med. 1986;146(9):1833–4.
Takata Y, Kurihara J, Suzuki S, Okubo Y, Kato H. A rabbit model for evaluation of chlorpromazine-induced orthostatic Shypotension. Biol Pharm Bull. 1999;22(5):457–62.
Nourian Z, Mow T, Muftic D, Burek S, Pedersen ML, Matz J, Mulvany MJ. Orthostatic hypotensive effect of antipsychotic drugs in Wistar rats by in vivo and in vitro studies of α 1-adrenoceptor function. Psychopharmacology. 2008;199(1):15.
Briggs R, Carey D, McNicholas T, Claffey P, Nolan H, Kennelly SP, Kenny RA. The association between antidepressant use and orthostatic hypotension in older people: a matched cohort study. J Am Soc Hypertens. 2018;12(8):597–604.
Mcdowell FH, Lee JE. Levodopa, Parkinson's disease, and hypotension. Ann Intern Med. 1970;72(5):751–2.
Kujawa K, Leurgans S, Raman R, Blasucci L, Goetz CG. Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease. Arch Neurol. 2000;57(10):1461–3.
Mehagnoul-Schipper DJ, Boerman RH, Hoefnagels WH, Jansen RW. Effect of levodopa on orthostatic and postprandial hypotension in elderly parkinsonian patients. J Gerontol Ser A Biol Med Sci. 2001;56(12):M749–55.
Piha SJ, Rinne JO, Rinne UK, Seppänen A. Autonomic dysfunction in recent onset and advanced Parkinson's disease. Clin Neurol Neurosurg. 1988;90(3):221–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kadioglu, S.B., Celik, T. (2021). Orthostatic Hypotension and Drugs: Drug-Induced Orthostatic Hypotension. In: Isik, A.T., Soysal, P. (eds) Orthostatic Hypotension in Older Adults. Springer, Cham. https://doi.org/10.1007/978-3-030-62493-4_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-62493-4_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-62492-7
Online ISBN: 978-3-030-62493-4
eBook Packages: MedicineMedicine (R0)